Reconstitution is the process of reintroducing a liquida diluentto bring it back into a solution for use
Single and multiple dose pharmacokinetics have been characterized in healthy subjects and HIV-infected patients without lipodystrophy using a 2 mg dose of EGRIFTA (1 mg/vial formulation)
Storage Store refrigerated at 28C
Product Specifications Test Results Sample: BPC-157, Thymosin B4-Fragment 500mcg/2.5mg Certificate of Analysis Certificate of Analysis Third-party tested for ~99% purity BPC-157 Properties Source: PubChem Form: Lyophilized powder Encapsulated Unit size: 500mcg Molecular formula: C 62 H 98 N 16 O 22 Molecular weight: 1419.5 g/mol Synonym: Bepecin, PLD-116 Sequence: GEPPPGKPADDAGLV CAS number: 37525-51-0 Encapsulation protects sensitive reference materials from oxidation
The peptide binds to GLP-1 receptors throughout the body, triggering a cascade of metabolic effects that include increased insulin secretion, decreased glucagon release, delayed gastric emptying, and reduced appetite signaling in the hypothalamus
Support for recovery, gut health and systemic repair